Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Delong Liu

Showing results (131-140 of 287) with videos related to

Pageof 29
Sort By:
Oncotarget|September 16, 2015
Novel agents for advanced pancreatic cancerAkintunde Akinleye, Chaitanya Iragavarapu, Muhammad Furqan, et al.
Journal of Hematology & Oncology|November 23, 2013
Phosphatidylinositol 3-kinase (PI3K) inhibitors as cancer therapeuticsAkintunde Akinleye, Parthu Avvaru, Muhammad Furqan, et al.
Current Diabetes Reviews|September 15, 2025
Efficacy and Safety of IDegLira in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Controlled TrialsLexie Bai, Delong Liu, Ning Su, et al.
Journal of Orthopaedic Surgery and Research|May 7, 2026
The role of Poller screws in intramedullary nailing for lower limb extra-isthmic fracturesZhanyu Yang, Bin Sheng, Delong Liu, et al.
Leukemia Research|March 24, 2004
Sweet's syndrome with CML cell infiltration of the skin in a patient with chronic-phase CML while taking Imatinib MesylateDelong Liu, Karen Seiter, Thomas Mathews, et al.
Journal of Hematology & Oncology|July 25, 2016
EGFR C797S mutation mediates resistance to third-generation inhibitors in T790M-positive non-small cell lung cancerShuhang Wang, Stella T Tsui, Christina Liu, et al.
Journal of Hematology & Oncology|February 6, 2010
Novel histone deacetylase inhibitors in clinical trials as anti-cancer agentsJiahuai Tan, Shundong Cang, Yuehua Ma, et al.
Experimental Hematology & Oncology|January 30, 2014
Ibrutinib for B cell malignanciesAileen Novero, Pavan M Ravella, Yamei Chen, et al.
Journal of Hematology & Oncology|January 14, 2016
Hypoacetylation, hypomethylation, and dephosphorylation of H2B histones and excessive histone deacetylase activity in DU-145 prostate cancer cellsShundong Cang, Xiaobin Xu, Yuehua Ma, et al.
Organic Letters|August 21, 2014
Asymmetric domino reaction of cyclic N-sulfonylimines and simple aldehydes with trans-perhydroindolic acid as an organocatalystQianjin An, Jiefeng Shen, Nicholas Butt, et al.
Pageof 29

Showing results (131-140 of 287) with videos related to

Sort By:
Pageof 29
Oncotarget|September 16, 2015
Novel agents for advanced pancreatic cancerAkintunde Akinleye, Chaitanya Iragavarapu, Muhammad Furqan, et al.
Journal of Hematology & Oncology|November 23, 2013
Phosphatidylinositol 3-kinase (PI3K) inhibitors as cancer therapeuticsAkintunde Akinleye, Parthu Avvaru, Muhammad Furqan, et al.
Current Diabetes Reviews|September 15, 2025
Efficacy and Safety of IDegLira in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Controlled TrialsLexie Bai, Delong Liu, Ning Su, et al.
Journal of Orthopaedic Surgery and Research|May 7, 2026
The role of Poller screws in intramedullary nailing for lower limb extra-isthmic fracturesZhanyu Yang, Bin Sheng, Delong Liu, et al.
Leukemia Research|March 24, 2004
Sweet's syndrome with CML cell infiltration of the skin in a patient with chronic-phase CML while taking Imatinib MesylateDelong Liu, Karen Seiter, Thomas Mathews, et al.
Journal of Hematology & Oncology|July 25, 2016
EGFR C797S mutation mediates resistance to third-generation inhibitors in T790M-positive non-small cell lung cancerShuhang Wang, Stella T Tsui, Christina Liu, et al.
Journal of Hematology & Oncology|February 6, 2010
Novel histone deacetylase inhibitors in clinical trials as anti-cancer agentsJiahuai Tan, Shundong Cang, Yuehua Ma, et al.
Experimental Hematology & Oncology|January 30, 2014
Ibrutinib for B cell malignanciesAileen Novero, Pavan M Ravella, Yamei Chen, et al.
Journal of Hematology & Oncology|January 14, 2016
Hypoacetylation, hypomethylation, and dephosphorylation of H2B histones and excessive histone deacetylase activity in DU-145 prostate cancer cellsShundong Cang, Xiaobin Xu, Yuehua Ma, et al.
Organic Letters|August 21, 2014
Asymmetric domino reaction of cyclic N-sulfonylimines and simple aldehydes with trans-perhydroindolic acid as an organocatalystQianjin An, Jiefeng Shen, Nicholas Butt, et al.
Pageof 29